Search research articles
Contact Us
Filters
Showing results (91-100 of 162) with videos related to
Page
of 17
Sort By:
Substance Use & Misuse
|
May 1, 2018
The Association between Distress Tolerance and Alcohol Related Problems: The Pathway of Drinking to Cope
A J Khan, P Pedrelli, B G Shapero, et al.
Pathology
|
March 12, 2014
Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products
Craig Wright, Zlatibor Velickovic, Ross Brown, et al.
Scientific Reports
|
January 26, 2018
Combined analysis of the salivary microbiome and host defence peptides predicts dental disease
A Simon-Soro, A Sherriff, S Sadique, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 16, 2004
Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS
Frances K Ngok, Ronald T Mitsuyasu, Janet L Macpherson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 16, 2004
Critical steps in the implementation of hematopoietic progenitor-cell gene therapy using ribozyme vectors: a laboratory protocol
Maureen P Boyd, Frances K Ngok, Alison V Todd, et al.
The West Indian Medical Journal
|
April 9, 2005
Cancer incidence and mortality in Grenada 1990-2000
Y Asulin, T J McCann, C W McCarty, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 23, 2020
Defining the Need for Dermatologic Surgery Global Health in an Afro-Caribbean Country
Nicole Ufkes, Audrey A Jacobsen, Doris J Joseph, et al.
Current Issues in Molecular Biology
|
July 27, 2001
The use of ribozyme gene therapy for the inhibition of HIV replication and its pathogenic sequelae
J E Rigden, J A Ely, J L Macpherson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma
M B Atkins, B Redman, J Mier, et al.
The Journal of Gene Medicine
|
September 25, 2009
Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV
John M Murray, Greg C Fanning, Janet L Macpherson, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 162) with videos related to
Sort By:
Page
of 17
Substance Use & Misuse
|
May 1, 2018
The Association between Distress Tolerance and Alcohol Related Problems: The Pathway of Drinking to Cope
A J Khan, P Pedrelli, B G Shapero, et al.
Pathology
|
March 12, 2014
Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products
Craig Wright, Zlatibor Velickovic, Ross Brown, et al.
Scientific Reports
|
January 26, 2018
Combined analysis of the salivary microbiome and host defence peptides predicts dental disease
A Simon-Soro, A Sherriff, S Sadique, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 16, 2004
Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS
Frances K Ngok, Ronald T Mitsuyasu, Janet L Macpherson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 16, 2004
Critical steps in the implementation of hematopoietic progenitor-cell gene therapy using ribozyme vectors: a laboratory protocol
Maureen P Boyd, Frances K Ngok, Alison V Todd, et al.
The West Indian Medical Journal
|
April 9, 2005
Cancer incidence and mortality in Grenada 1990-2000
Y Asulin, T J McCann, C W McCarty, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 23, 2020
Defining the Need for Dermatologic Surgery Global Health in an Afro-Caribbean Country
Nicole Ufkes, Audrey A Jacobsen, Doris J Joseph, et al.
Current Issues in Molecular Biology
|
July 27, 2001
The use of ribozyme gene therapy for the inhibition of HIV replication and its pathogenic sequelae
J E Rigden, J A Ely, J L Macpherson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma
M B Atkins, B Redman, J Mier, et al.
The Journal of Gene Medicine
|
September 25, 2009
Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV
John M Murray, Greg C Fanning, Janet L Macpherson, et al.
Page
of 17